| DDOG |
Report |
Q2 2026 revenue |
BEAT |
pred ~$1.104B vs. cons $1.077B |
MEDIUM |
| DDOG |
Report |
Q2 2026 non-GAAP EPS |
BEAT |
pred ~$0.64 vs. cons $0.60 |
MEDIUM |
| DDOG |
Report |
Q2 2026 non-GAAP operating income |
BEAT |
pred ~$255M vs. cons $238M |
LOW |
| DDOG |
Guide |
Q3 2026 revenue guidance |
BETTER |
guide ~$1.125B vs. cons $1.116B (Q3 2026) |
MEDIUM |
| DDOG |
Guide |
FY2026 revenue guidance |
BETTER |
guide ~$4.460B vs. cons $4.350B (FY2026) |
MEDIUM |
| DDOG |
Guide |
Q3 2026 non-GAAP EPS guidance |
BETTER |
guide ~$0.62 vs. cons $0.61 (Q3 2026) |
LOW |
| DDOG |
Guide |
FY2026 non-GAAP EPS guidance |
BETTER |
guide ~$2.56 vs. cons $2.42 (FY2026) |
MEDIUM |
| DDOG |
Return |
Day-1 residual (stock − beta × S&P 500) |
+4.5% |
— |
LOW |
| DDOG |
Return |
5-day cumulative residual |
+7.0% (FOLLOW-THROUGH) |
The predicted FY2026 revenue guide implies roughly $2.350B of second-half revenue versus approximately $2.267B embedded in consensus, supporting positive out-period estimate revisions after the Q2 beat; elevated valuation and buy-side expectations limit confidence. |
LOW |